SEnIORIT - Escola Superior de Tecnologia da Saúde de Coimbra
SEnIORIT - Escola Superior de Tecnologia da Saúde de Coimbra
SEnIORIT - Escola Superior de Tecnologia da Saúde de Coimbra
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ucts for launch. ViroGates A/S has so<br />
far invested more than USD 10M in<br />
private capital over the past <strong>de</strong>ca<strong>de</strong> to<br />
make suPARnostic® accessible to the<br />
medical profession.<br />
Recent published articles about suPAR:<br />
Elevated soluble urokinase plasminogen activator receptor<br />
(suPAR) predicts mortality in Staphylococcus<br />
aureus bacteremia<br />
T. Mölkänen, E. Ruotsalainen, C. W. Thorball , A. Järvinen<br />
Eur J Clin Microbiol Infect Dis. 2011 Mar 20. DOI 10.1007/s10096-011-1236-8<br />
suPAR – A future risk marker<br />
Eugen-Olsen J.<br />
J Intern Med. 2011 Mar 3. doi: 10.1111/j.1365-2796.2011.02372.x.<br />
Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease<br />
severity and case fatality in patients with bacteraemia: aprospective cohort study<br />
Huttunen R, Syrjänen R, Vuento R, Hurme M, Huhtala H, Laine J, Pessi T, Aittoniemi J.<br />
Journal of Internal Medicine. 2011 Feb. DOI: 10.1111/j.1365-2796.2011.02363.x<br />
Increased plasma soluble uPAR level is a risk marker of respiratory cancer in initially cancer-free individuals.<br />
Langkil<strong>de</strong> AA, Hansen TW, La<strong>de</strong>lund S, Linneberg A, An<strong>de</strong>rsen O, Haugaard SB, Jeppesen J, Eugen-Olsen J.<br />
Cancer Epi<strong>de</strong>miol Biomarkers Prev. 2011 Jan 14.<br />
Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week<br />
of treatment in the intensive care unit and predicts mortality in critically ill patients.<br />
Koch A, Voigt S, Kruschinski C, Sanson E, Dückers H, Horn A, Yagmur E, Zimmermann H, Trautwein C,<br />
Tacke F. Crit Care. 2011 Feb 16;15(1):R63<br />
Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Organ Damage<br />
And Cardiovascular Events.<br />
T. Sehestedt, S. Lyngbæk, J. Eugen-Olsen, J. Jeppesen, O. An<strong>de</strong>rsen, T.W. Hansen, A. Linneberg, T.<br />
Jørgensen, S.B. Haugaard and M.H. Olsen<br />
Atherosclerosis. 2011 Feb 22. doi:10.1016/<br />
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular<br />
disease, diabetes and mortality in the general population.<br />
Eugen-Olsen J, An<strong>de</strong>rsen O, Linneberg A, La<strong>de</strong>lund S, Hansen TW, Langkil<strong>de</strong> A, Petersen J, Pielak T, Møller LN,<br />
Jeppesen J, Lyngbaek S, Fenger M, Olsen MH, Hil<strong>de</strong>brandt PR, Borch-Johnsen K, Jørgensen T, Haugaard SB.<br />
J Intern Med. 2010 Sep;268(3):296-308.<br />
22 Bioanalyytikko 2/2011<br />
Further Information<br />
Please contact: Jussi Kontturi, Electra-Box<br />
Diagnostica Oy<br />
(+358 (0)9 7244330 or jussi.kontturi@electrabox.com)
Change language